Related Experiment Video
Updated: Aug 14, 2026
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
[Diarrhea and enteral nutrition]
M Pons Busom1, M Aguas Compaired, N de la Concepción de Lucas
1Servicio de Farmacia, Quinta de Salud La Alianza, Hospital Central, Barcelona.
Nutricion Hospitalaria
|January 1, 1992
Summary
Diarrhoea in patients receiving enteral nutrition is poorly understood, with significant discrepancies in evaluation due to varied definitions and methods. This review analyzes contributing factors and highlights the need for standardized approaches.
Area of Science:
- Gastroenterology
- Clinical Nutrition
- Patient Care
Background:
- Enteral nutrition is crucial for patients unable to consume food orally.
- Diarrhoea is a common complication in patients receiving enteral nutrition.
- Current understanding and management of enteral nutrition-associated diarrhoea (ENAD) lack standardization.
Purpose of the Study:
- To review the definition and understanding of diarrhoea in patients on enteral nutrition.
- To analyze factors contributing to the development of diarrhoea during enteral feeding.
- To identify discrepancies in the evaluation of enteral nutrition-induced diarrhoea.
Main Methods:
- Literature review of studies on diarrhoea in patients on enteral nutrition.
- Analysis of factors related to diet preparation and administration.
- Examination of patient-specific factors influencing diarrhoea.
- Assessment of differing definitions, methods, and exclusion criteria used in studies.
Main Results:
- Significant discrepancies exist in evaluating diarrhoea associated with enteral diets.
- Variations in diarrhoea definitions, methodologies, and exclusion criteria contribute to these discrepancies.
- Factors related to enteral formula preparation, administration, and patient characteristics play a role.
Conclusions:
- The evaluation of diarrhoea in patients on enteral nutrition is inconsistent.
- Standardized definitions and methodologies are needed for accurate assessment and management of ENAD.
- Further research is required to elucidate the multifactorial causes of ENAD.
Related Concept Videos
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:26Enteral Nutrition I: Orogastric and Nasogastric Feeding
Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
01:15Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...